EPISODE · Jun 18, 2025 · 18 MIN
#504 - Bill Taranto, President at Merck Global Health Innovation Fund
from Slice of Healthcare · host Slice of Media, Inc.
Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Bill Taranto, President at Merck Global Health Innovation Fund.What you’ll get out of this episode:Bill Taranto’s Journey: From Johnson & Johnson to leading Merck’s $600M GHI Fund focused on digital health and technology.Four Core Investment Areas: Drug discovery, clinical development, supply chain, and patient access/data.Portfolio Spotlights: Companies like Npower, Unnatural Products, Aerosafe Global, Cure AI, and Prognos are driving impactful innovation.Strategic Value of CVCs: Beyond capital, CVCs offer startups technical expertise, commercial agreements, and long-term support.Navigating Market Challenges: Insights on VC pullback, consolidation trends, and advice for startups on sustainable growth.To learn more about Merck:Website https://www.merck.com/ Linkedin https://www.linkedin.com/company/merck/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.
What this episode covers
Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Bill Taranto, President at Merck Global Health Innovation Fund.What you’ll get out of this episode:Bill Taranto’s Journey: From Johnson & Johnson to leading Merck’s $600M GHI Fund focused on digital health and technology.Four Core Investment Areas: Drug discovery, clinical development, supply chain, and patient access/data.Portfolio Spotlights: Companies like Npower, Unnatural Products, Aerosafe Global, Cure AI, and Prognos are driving impactful innovation.Strategic Value of CVCs: Beyond capital, CVCs offer startups technical expertise, commercial agreements, and long-term support.Navigating Market Challenges: Insights on VC pullback, consolidation trends, and advice for startups on sustainable growth.To learn more about Merck:Website https://www.merck.com/ Linkedin https://www.linkedin.com/company/merck/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.
NOW PLAYING
#504 - Bill Taranto, President at Merck Global Health Innovation Fund
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m